In 2022, the global ventral hernia treatment industry reached a value of US$4.75 billion, and it is anticipated to reach US$9.4 billion by 2033, with a projected CAGR of 6.4% during the forecast period from 2023 to 2033. The growth of this market can be attributed to several factors, including the increasing incidence of ventral hernias, rising demand for minimally invasive surgical procedures, the growing elderly population, and the availability of advanced products and services. From 2018 to 2022, the ventral hernia treatment industry showed a historical CAGR of 3.3%.
Ventral hernia is a medical condition characterized by the protrusion of a portion of the intestines or other abdominal tissue through a weakened area of the abdominal muscles, resulting in a visible bulge or protrusion on the skin’s surface.
Request a Sample Copy of the Report Now
https://www.futuremarketinsights.com/reports/sample/rep-gb-17034
The availability of sophisticated hernia repair technologies and solutions is also helping to drive the Ventral Hernia Treatment industry forward. Companies such as Medtronic and Becton Dickinson & Company support the weaker or injured tissue in the abdominal wall and help prevent the hernia from returning are developing innovative mesh solutions and surgical devices. When compared to traditional hernia repair methods, these products are frequently designed to be minimally invasive and have improved safety and efficacy profiles.
Key Takeaways from the Market Study
- From 2023 to 2033, the global Ventral Hernia Treatment industry is predicted to rise at a 6.4% CAGR.
- In 2023, hospitals are estimated to hold 48% of the market share for Ventral Hernia Treatment.
- In 2023, North America is anticipated to have 46% of the Ventral Hernia Treatment market.
- In 2023, Europe’s Ventral Hernia Treatment industry is estimated to account for 38% of the total.
“The rising geriatric population and the increasing demand for better healthcare infrastructure in emerging economies are expected to drive the growth of the market in the coming years,” states an FMI analyst
Examining the study’s underlying assumptions. Ask an analyst
https://www.futuremarketinsights.com/ask-question/rep-gb-17034
Competitive Landscape
Key players in the Ventral Hernia Treatment industry are Medtronic, Becton Dickinson & Company, Braun Melsungen AG, Cook Medical Inc., Cooper Companies Inc., Baxter International, Inc., Integra LifeSciences, W.L. Gore & Associates, AbbVie, Johnson & Johnson Services, Inc.
- Medtronic has developed minimally invasive surgical techniques and technologies that can be used to repair ventral hernias. These techniques often result in less pain and scarring, shorter hospital stays, and faster recovery times for patients.
- Becton Dickinson & Company collaborates with healthcare professionals to develop and improve hernia treatment solutions. This includes conducting clinical research and providing training and education to surgeons and other medical professionals.
More Valuable Insights
Future Market Insights, in its new offering, presents an unbiased analysis of the global Ventral Hernia Treatment market, presenting a historical analysis from 2018 to 2022 and forecast statistics for the period of 2023 to 2033.
The study reveals essential insights based on Type (Epigastric (stomach area) hernia, Umbilical (belly button) hernia, Incisional hernia) Diagnosis (Ultrasound, CT Scan, MRI) Surgery Type (Open hernia surgery, Laparoscopic surgery, Robotic hernia surgery) End-use (Hospitals, Ambulatory Surgical Centres, Clinics) Region (North America, Latin America, Europe, South Asia, East Asia, Oceania)
Access Exclusive Market Insights – Purchase Now!
https://www.futuremarketinsights.com/checkout/17034
Key Segments Profiled in the Ventral Hernia Treatment Industry Survey
Type:
- Epigastric (stomach area) hernia
- Umbilical (belly button) hernia
- Incisional hernia
Diagnosis:
- Ultrasound
- CT Scan
- MRI
Surgery Type:
- Open hernia surgery
- Laparoscopic surgery
- Robotic hernia surgery
End-use:
- Hospitals
- Ambulatory Surgical Centres
- Clinics
About Future Market Insights (FMI)
Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 5,000 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.
Contact Us:
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube
